Hong Kong stock market anomaly | Biopharmaceutical stocks are performing well, with recent positive developments in the pharmaceutical industry. Institutions are optimistic about the continued prosperity of innovative drugs.

According to the Securities Times app, biopharmaceutical stocks are performing actively. As of the time of writing, Zhao Yan's new drug (06127.HK) rose 10.67% to HK$18.46; Fudan Zhangjiang (01349.HK) rose 8.53% to HK$3.69; Beihai Kangcheng-B (01228.HK) rose 7.89% to HK$0.41; and Fangda Holdings (01521) rose 3.25% to HK$1.27.